Growth Hormone Therapy Is Safe and Effective in Patients with Lysinuric Protein Intolerance

Background: Lysinuric protein intolerance (LPI) is an autosomal recessive cationic amino acid transport defect characterized by episodes of postprandial hyperammonemias and spontaneous protein aversion. Subnormal growth is common in spite of appropriate nutritional therapy. Growth hormone (GH) thera...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Niinikoski, Harri, Lapatto, Risto, Nuutinen, Matti, Tanner, Laura, Simell, Olli, Näntö-Salonen, Kirsti
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509816/
https://ncbi.nlm.nih.gov/pubmed/23430827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_15
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller